Tumor |
Author |
Year |
Method |
No. of Patients |
Title |
Journal |
Abstract Link |
Soft Tissue Sarcoma |
Lindner |
2021 |
HT |
# |
Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas |
Eur J Cancer |
 |
Soft Tissue Sarcoma |
Issels |
2021 |
CT+HT |
109 |
Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial |
Eur J Cancer |
 |
Soft Tissue Sarcoma |
Issels |
2020 |
HT |
109 |
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma – a case report |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Bücklein |
2020 |
ICE+HT |
110 |
Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma |
Sarcoma |
 |
Soft Tissue Sarcoma |
Aklan |
2019 |
HT |
# |
Regional deep hyperthermia: quantitative evaluation of predicted and direct measured temperature distributions in patients with high-risk extremity soft-tissue sarcoma |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Zschaeck |
2018 |
CT+HT |
61 |
Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Issels |
2018 |
CT vs. CT+HT |
341 |
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. |
JAMA |
 |
Soft Tissue Sarcoma |
Eckert |
2017 |
CT+HT |
42 |
Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Angele |
2014 |
CT vs. CT+HT |
341 |
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. |
Ann Surg Oncol |
 |
Soft Tissue Sarcoma |
Issels |
2010 |
CT vs. CT+HT |
341 |
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. |
Lancet |
 |
Soft Tissue Sarcoma |
Schlemmer |
2010 |
RCT+HT |
47 |
Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS) |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Fiegl |
2004 |
CT+HT |
20 |
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults. |
Int J Hyperthermia |
 |
Soft Tissue Sarcoma |
Wendtner |
2002 |
CT+HT |
58 |
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. |
JCO |
 |
Soft Tissue Sarcoma |
Issels |
2001 |
CT+HT |
59 |
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. |
Eur J Cancer |
 |
Soft Tissue Sarcoma |
Wendtner |
2001 |
RCT+HT |
54 |
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. |
Eur J Cancer |
 |
Soft Tissue Sarcoma |
Prosnitz |
1999 |
RT+HT |
97 |
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. |
IJRO |
 |
Soft Tissue Sarcoma |
Scully |
1994 |
RT+HT |
40 |
Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas |
J Surg Oncol |
 |
Soft Tissue Sarcoma |
Issels |
1990 |
CT+HT |
40 |
Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. |
JCO |
 |